Synedica Laboratories

Growth Hormone Axis

Ipamorelin

Selective GHSR-1a agonist studied as a clean model of pulsatile GH release, with little change in cortisol, prolactin or ACTH.

Also known asNNC 26-0161

Identity

Residue chain

One bead per amino acid residue, N-terminus to C-terminus. Long chains are shown truncated.

Molecular weight
711.9 Da
Amino acid residues
5
Half-life
~2 h
CAS number
170851-70-4

Monograph

Specifications

Research area
Growth Hormone Axis
Half-life
~2 h
Molecular weight
711.9 Da
Amino acid residues
5
CAS number
170851-70-4
Formula
C₃₈H₄₉N₉O₅
Sequence
Aib-His-D-2-Nal-D-Phe-Lys-NH₂
Designation
H-Aib-His-D-2-Nal-D-Phe-Lys-NH₂ (pentapeptide GHS)

Pharmacokinetics

Half-life
~2 h
T-max
~30 min
Route
Subcutaneous (research use)

Receptor targets

  • GHSR-1aSelective ghrelin-receptor agonist
  • Anterior pituitary somatotrophsPulsatile GH release

Signalling cascade

  1. 1GHSR-1a binding
  2. 2Gq/PLC activation
  3. 3Ca²⁺ release
  4. 4Pulsatile GH secretion
  5. 5IGF-1 ↑
Mechanism of action
Selective GH secretagogue receptor (GHSR-1a) agonist that stimulates pulsatile growth hormone release from the anterior pituitary without significant elevation of cortisol, prolactin, or ACTH. Provides a clean model for studying GH pulse dynamics and downstream IGF-1 signaling.
Storage and handling
Refrigerate at 2–8 °C after reconstitution. The powder is stable at room temperature for up to 18 months.

Research focus

  • 01Pulsatile GH release and GHSR-1a receptor pharmacology
  • 02Anabolic signaling and lean mass regulation via IGF-1 axis
  • 03Cortisol and prolactin independence in GH stimulation models
  • 04Appetite modulation through ghrelin pathway interaction
  • 05Body composition research in rodent models

Overview

Ipamorelin is a synthetic pentapeptide and selective GHSR-1a agonist. It stimulates pulsatile GH release from the anterior pituitary without raising cortisol, prolactin or ACTH, which is why it is used to follow the GH axis and the IGF-1 response without those confounders.